-
Publication Venue For
-
Association of Acute Kidney Injury and Cardiovascular Disease Following Percutaneous Coronary Intervention: Assessment of Interactions by Race, Diabetes, and Kidney Function..
81:707-716.
2023
-
Daratumumab Use Prior to Kidney Transplant and T Cell-Mediated Rejection: A Case Report..
81:616-620.
2023
-
Epidemiology of Community-Acquired Acute Kidney Injury Among US Veterans.
2023
-
Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials..
81:281-293.e1.
2023
-
Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease..
81:318-328.e1.
2023
-
Antiviral Treatment Failures After Transplantation of Organs From Donors With Hepatitis C Infection: A Report of 4 Cases.
2023
-
A National Registry for People With All Stages of Kidney Disease: The National Kidney Foundation (NKF) Patient Network..
81:210-221.e1.
2023
-
Supermarket Proximity and Risk of Hypertension, Diabetes, and CKD: A Retrospective Cohort Study..
81:168-178.
2023
-
Race, Ancestry, and Genetic Risk for Kidney Failure..
80:801-804.
2022
-
Referral and Evaluation for Kidney Transplantation Following Implementation of the 2014 National Kidney Allocation System..
80:707-717.
2022
-
Acute Kidney Injury in a Patient With a Kidney Transplant and Posttransplant Lymphoproliferative Disorder: A Quiz..
80:A20-A22.
2022
-
Estimation of Black-White Disparities in CKD Outcomes: Comparison Using the 2021 Versus the 2009 CKD-EPI Creatinine Equations..
80:423-426.
2022
-
Outscoring Current Classification Systems for Nephrotic Syndrome..
79:783-784.
2022
-
Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome..
79:807-819.e1.
2022
-
Only Part of the Story..
79:A11-A12.
2022
-
Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study..
79:404-416.e1.
2022
-
Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes..
79:393-403.e1.
2022
-
Research Priorities for Kidney-Related Research-An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation..
79:141-152.
2022
-
Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study..
79:36-44.e1.
2022
-
Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study..
78:837-845.e1.
2021
-
Reconsidering Plant-Based Diets in Patients Receiving Maintenance Hemodialysis..
78:624-626.
2021
-
Diarrhea in a Patient With Combined Kidney-Pancreas Transplant..
78:A13-A16.
2021
-
Eight Years of AJKD Blog-Lessons Learned and What Lies Ahead..
78:168-170.
2021
-
Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study..
78:38-47.
2021
-
Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study..
77:907-919.
2021
-
Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis..
77:920-930.e1.
2021
-
Mobile Health (mHealth) Technology: Assessment of Availability, Acceptability, and Use in CKD..
77:941-950.e1.
2021
-
Prevention of Urinary Stones With Hydration (PUSH): Design and Rationale of a Clinical Trial..
77:898-906.e1.
2021
-
Racism and Kidney Health: Turning Equity Into a Reality..
77:951-962.
2021
-
A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population..
77:673-683.e1.
2021
-
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study..
77:235-244.
2021
-
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States..
77:190-203.e1.
2021
-
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study..
77:56-73.e1.
2021
-
State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective..
77:132-141.
2021
-
Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference..
76:842-850.
2020
-
Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis..
76:868-876.
2020
-
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study..
76:511-520.
2020
-
Performance of Indexed and Nonindexed Estimated GFR..
76:446-449.
2020
-
Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study..
76:184-193.
2020
-
Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study..
75:908-918.
2020
-
Pulmonary Hypertension Subtypes and Mortality in CKD..
75:713-724.
2020
-
Diagnosis and Management of Disorders of Body Tonicity-Hyponatremia and Hypernatremia: Core Curriculum 2020..
75:272-286.
2020
-
Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study..
75:235-244.
2020
-
Implantable Defibrillators for Primary Prevention of Sudden Death in Patients on Dialysis..
74:857-860.
2019
-
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD..
74:771-781.
2019
-
Déjà Vu But New: Using T Cells to Deplete B Cells to Treat Lupus..
74:708-710.
2019
-
Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study..
74:203-212.
2019
-
A Delicate Balance: Intraglomerular Hemodynamics Across Ages in Type 1 Diabetes..
73:759-761.
2019
-
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study..
73:806-814.
2019
-
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study..
73:344-353.
2019
-
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease..
73:218-229.
2019
-
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium..
73:206-217.
2019
-
Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial..
73:51-61.
2019
-
The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation..
72:834-845.
2018
-
Genetic Basis of Health Disparity in Childhood Nephrotic Syndrome..
72:S22-S25.
2018
-
Improving Primary Care for Patients With CKD in the Digital Era..
72:159-160.
2018
-
New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat..
72:7-9.
2018
-
The Relationship of Quantitative Retinal Capillary Network to Kidney Function in Type 2 Diabetes..
71:916-918.
2018
-
HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome..
71:399-406.
2018
-
NephMadness After 5 Years: A Recap and Game Plan for the Future..
71:299-301.
2018
-
Baclofen Toxicity in Kidney Disease..
71:275-280.
2018
-
Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD..
71:267-274.
2018
-
Acid Load and Phosphorus Homeostasis in CKD..
70:541-550.
2017
-
Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort..
70:377-385.
2017
-
Serious Fall Injuries Before and After Initiation of Hemodialysis Among Older ESRD Patients in the United States: A Retrospective Cohort Study..
70:76-83.
2017
-
Urinary Anomalies in 22q11.2 Deletion (DiGeorge syndrome): From Copy Number Variations to Single-Gene Determinants of Phenotype..
70:8-10.
2017
-
Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex..
69:771-779.
2017
-
The Evolution of the Journal Club: From Osler to Twitter..
69:827-836.
2017
-
Sudden Cardiac Death Among Hemodialysis Patients..
69:684-695.
2017
-
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies..
68:545-553.
2016
-
Cause Unknown, Treatment Uncertain, Outcome Poor: An Encounter With Kidney Failure in the Developing World..
68:A15-A16.
2016
-
Risk Factors for Rapid Kidney Function Decline Among African Americans: The Jackson Heart Study (JHS)..
68:229-239.
2016
-
Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage..
68:94-102.
2016
-
Acute Kidney Injury in Low-Resource Settings: Barriers to Diagnosis, Awareness, and Treatment and Strategies to Overcome These Barriers..
67:834-840.
2016
-
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial..
67:648-659.
2016
-
Opioid Use in Hemodialysis Patients..
66:1103-1105.
2015
-
Patient-Reported Outcome Instruments for Physical Symptoms Among Patients Receiving Maintenance Dialysis: A Systematic Review..
66:1033-1046.
2015
-
Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR..
66:1006-1014.
2015
-
Self-reported Medication Adherence and Adverse Patient Safety Events in CKD..
66:621-629.
2015
-
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial..
66:479-488.
2015
-
Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies..
66:258-265.
2015
-
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study..
66:106-113.
2015
-
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5..
65:728-736.
2015
-
Patients as stakeholders in setting kidney disease research priorities..
65:641-643.
2015
-
Effect of low versus high dialysate sodium concentration on blood pressure and endothelial-derived vasoregulators during hemodialysis: a randomized crossover study..
65:464-473.
2015
-
NephMadness 2015: nephrology as a cornerstone of medicine..
65:375-377.
2015
-
Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study..
65:249-258.
2015
-
Diabetic kidney disease: a report from an ADA Consensus Conference..
64:510-533.
2014
-
Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study..
64:443-451.
2014
-
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials..
64:32-39.
2014
-
Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD..
63:806-815.
2014
-
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study..
63:781-788.
2014
-
The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov..
63:771-780.
2014
-
Community mobility among older adults with reduced kidney function: a study of life-space..
63:429-436.
2014
-
Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality..
63:16-22.
2014
-
Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study..
62:900-907.
2013
-
Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review..
62:953-973.
2013
-
Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study..
62:670-678.
2013
-
Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation..
62:457-473.
2013
-
Role of vaptans in the management of hyponatremia..
62:364-376.
2013
-
Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System..
62:312-321.
2013
-
Urinary cystatin C and acute kidney injury after cardiac surgery..
61:730-738.
2013
-
Usability testing and acceptance of an electronic medication inquiry system for CKD patients..
61:644-646.
2013
-
Why not nephrology? A survey of US internal medicine subspecialty fellows..
61:540-546.
2013
-
Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trial..
61:476-486.
2013
-
Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study..
61:395-403.
2013
-
A physiologic-based approach to the evaluation of a patient with hyperphosphatemia..
61:330-336.
2013
-
Comparative effectiveness research in kidney disease: a national priority..
61:9-12.
2013
-
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD..
61:67-73.
2013
-
The state of the blog: the first year of eAJKD..
61:1-2.
2013
-
Metabolic complications in elderly adults with CKD..
60:893-895.
2012
-
Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study..
60:922-929.
2012
-
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial..
60:390-401.
2012
-
A varying patient safety profile between black and nonblack adults with decreased estimated GFR..
60:47-53.
2012
-
Changing terminology in renal research: the impact of consensus..
59:584-585.
2012
-
Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study..
59:495-503.
2012
-
Managing older adults with CKD: individualized versus disease-based approaches..
59:293-302.
2012
-
Embracing the Internet as a means of enhancing medical education in nephrology..
58:512-518.
2011
-
Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery..
58:366-373.
2011
-
High-normal albuminuria and risk of heart failure in the community..
58:47-55.
2011
-
Retinal arteriolar narrowing and subsequent development of CKD Stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA)..
58:39-46.
2011
-
Antifibrinolytic use during cardiac and hepatic surgery makes tubular proteinuria-based early biomarkers poor tools to diagnose perioperative acute kidney injury..
57:960.
2011
-
Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review..
57:592-601.
2011
-
Quality of patient-physician discussions about CKD in primary care: a cross-sectional study..
57:583-591.
2011
-
Geographic and temporal trends in peritoneal dialysis services in the United States between 1995 and 2003..
55:1079-1087.
2010
-
Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry..
55:316-325.
2010
-
Care of the undocumented immigrant in the United States with ESRD..
55:181-191.
2010
-
Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study..
54:881-890.
2009
-
Prevalence of major depressive episode in CKD..
54:424-432.
2009
-
Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians..
54:227-237.
2009
-
Cryoglobulinemia and glomerular rhomboid inclusions in a child with acute kidney injury..
53:866-870.
2009
-
The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial..
53:638-646.
2009
-
Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes..
53:426-437.
2009
-
Population-based screening for CKD..
53:S64-S70.
2009
-
Two rare forms of renal allograft glomerulopathy during cytomegalovirus infection and treatment..
51:1047-1051.
2008
-
Challenges for public campaigns to improve the health of persons at high risk of developing CKD..
51:535-538.
2008
-
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease..
50:946-951.
2007
-
Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?.
50:904-907.
2007
-
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients..
50:108-118.e4.
2007
-
Reporting of estimated GFR in the primary care clinic..
49:634-641.
2007
-
Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial..
48:739-751.
2006
-
The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease..
48:e55-e59.
2006
-
Impaired muscle oxygen metabolism in uremic children: improved after renal transplantation..
48:473-480.
2006
-
Identification and referral of patients with progressive CKD: a national study..
48:192-204.
2006
-
HIV-associated nephropathy: a case study in race and genetics..
47:1084-1085.
2006
-
Facilitated process improvement: an approach to the seamless linkage between evidence and practice in CKD..
47:528-538.
2006
-
Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis..
46:642-649.
2005
-
CKD progression and mortality among older patients with diabetes..
46:406-414.
2005
-
Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study..
46:214-224.
2005
-
Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery..
45:519-530.
2005
-
The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure..
44:207-215.
2004
-
Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients..
42:1260-1269.
2003
-
Coronary steal from a left internal mammary artery coronary bypass graft by a left upper extremity arteriovenous hemodialysis fistula..
40:852-855.
2002
-
The uneven distribution of kidney transplants: getting at the root causes and improving care..
40:861-863.
2002
-
Evaluation of an antimicrobial-impregnated continuous ambulatory peritoneal dialysis catheter for infection control in rats..
39:165-173.
2002
-
Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate..
38:744-753.
2001
-
Evaluation of disease-state management of dialysis patients..
37:938-944.
2001
-
Viral infections after renal transplantation..
37:659-676.
2001
-
Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States..
37:366-373.
2001
-
Angiotensin II: an immune costimulator?.
36:434-440.
2000
-
Antibodies to topical bovine thrombin correlate with access thrombosis..
35:796-801.
2000
-
Using renal transplantation to evaluate a simple approach for predicting the impact of end-stage renal disease therapies on patient survival: observed/expected life span..
35:653-659.
2000
-
Life expectancy benefits of cancer screening in the end-stage renal disease population..
35:237-243.
2000
-
Staphylococcus aureus pneumonia, hyponatremia, hypertension, proteinuria, and hematuria in a 14-year-old boy..
35:354-359.
2000
-
Reducing the risk of hemodialysis access..
34:362-363.
1999
-
Role of urine and serum protein electrophoresis in evaluation of nephrotic-range proteinuria..
34:135-139.
1999
-
Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation..
33:970-974.
1999
-
SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells..
31:418-426.
1998
-
Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration.
2022
-
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
2022
-
Validation of depression screening scales in patients with CKD.
2009